4.4 Article

The Impact of Depth of Infection and Postdischarge Surveillance on Rate of Surgical-Site Infections in a Network of Community Hospitals

Journal

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Volume 33, Issue 3, Pages 276-282

Publisher

UNIV CHICAGO PRESS
DOI: 10.1086/664053

Keywords

-

Funding

  1. Robert Wood Johnson Foundation Physician Faculty
  2. National Institute of Allergy and Infectious Diseases [1K23AI095357-01]

Ask authors/readers for more resources

OBJECTIVE. To describe the epidemiology of surgical-site infections (SSIs) in community hospitals and to explore the impact of depth of SSI, healthcare location at the time of diagnosis, and variations in surveillance practices on the overall rate of SSI. DESIGN. Retrospective cohort study. SETTING. Thirty-seven community hospitals in the southeastern United States. PATIENTS. Consecutive sample of patients undergoing surgical procedures between July 1, 2007, and December 31, 2008. METHODS. ANOVA was used to compare rates of SSIs, and the F test was used to compare the distribution of rates of SSIs. Wilcoxon rank-sum was used to test for differences in performance rankings of hospitals. RESULTS. Following 177,706 surgical procedures, 1,919 SSIs were identified (incidence, 1.08 per 100 procedures). Sixty-four percent (1,223 of 1,919) of these were identified as complex SSIs; 87% of the complex SSIs were diagnosed in inpatient settings. The median proportion of superficial-incisional SSIs was 37% (interquartile range, 29.6%-49.5%). Postdischarge SSI surveillance was variable, with 58% of responding hospitals using surgeon letters. As reporting focus was narrowed from all SSIs to complex SSIs (incidence, 0.69 per 100 procedures) and, finally, to complex SSIs diagnosed in the inpatient setting (incidence, 0.51 per 100 procedures), variance in rates changed significantly (P = .02). Performance ranking of individual hospitals, based on rates of SSIs, differed significantly, depending on the reporting method utilized (P = .0006). CONCLUSIONS. Inconsistent reporting methods focused on variable depths of infection and healthcare location at time of diagnosis significantly impact rates of SSI, distribution of rates of SSI, and hospital comparative-performance rankings. We believe that public reporting of SSI rates should be limited to complex SSIs diagnosed in the inpatient setting.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Public, Environmental & Occupational Health

Are we forgetting the universal in universal masking? Current challenges and future solutions

Sonali D. Advani, Michael E. Yarrington, Becky A. Smith, Deverick J. Anderson, Daniel J. Sexton

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2021)

Editorial Material Immunology

Is Long-term Oral Therapy for Treatment of Bone and Joint Infections Ready for Prime Time?

Jessica Seidelman, Daniel J. Sexton

CLINICAL INFECTIOUS DISEASES (2021)

Article Public, Environmental & Occupational Health

Coronavirus disease 2019 (COVID-19) research agenda for healthcare epidemiology

Lona Mody, Ibukunoluwa C. Akinboyo, Hilary M. Babcock, Werner E. Bischoff, Vincent Chi-Chung Cheng, Kathleen Chiotos, Kimberly C. Claeys, K. C. Coffey, Daniel J. Diekema, Curtis J. Donskey, Katherine D. Ellingson, Heather M. Gilmartin, Shruti K. Gohil, Anthony D. Harris, Sara C. Keller, Eili Y. Klein, Sarah L. Krein, Jennie H. Kwon, Adam S. Lauring, Daniel J. Livorsi, Eric T. Lofgren, Katreena Merrill, Aaron M. Milstone, Elizabeth A. Monsees, Daniel J. Morgan, Luci P. Perri, Christopher D. Pfeiffer, Clare Rock, Sanjay Saint, Emily Sickbert-Bennett, Felicia Skelton, Katie J. Suda, Thomas R. Talbot, Valerie M. Vaughn, David J. Weber, Timothy L. Wiemken, Mohamed H. Yassin, Matthew J. Ziegler, Deverick J. Anderson

Summary: This white paper identifies knowledge gaps and challenges in healthcare epidemiology research related to COVID-19 and proposes a research agenda. It emphasizes the need for collaboration across disciplines and addresses issues related to nursing homes and social disparities.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Article Public, Environmental & Occupational Health

Burden of healthcare-associated infections among hospitalized children within community hospitals participating in an infection control network

Ibukunoluwa C. Akinboyo, Rebecca R. Young, Michael J. Smith, Sarah S. Lewis, Becky A. Smith, Deverick J. Anderson

Summary: Through prospective surveillance in community hospitals, 84 pediatric healthcare-associated infections were identified over a 6-year period. 61% of these infections were pediatric central-line-associated bloodstream infections, and they often occurred in children under 1 year of age.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Article Medicine, General & Internal

Estimated Methicillin-Resistant Staphylococcus aureus Decolonization in Intensive Care Units Associated With Single-Application Chlorhexidine Gluconate or Mupirocin

Eric T. Lofgren, Matthew Mietchen, Kristen V. Dicks, Rebekah Moehring, Deverick Anderson

Summary: The study suggests that there is significant room for improvement in anti-MRSA disinfectants, including both the compounds themselves and their delivery mechanisms. Despite the decolonization estimates found in this study, these agents have robust outcomes even after delays in administration, which may help alleviate concerns over patient comfort and toxic effects.

JAMA NETWORK OPEN (2021)

Article Medicine, General & Internal

SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason

Christina D. Mack, John DiFiori, Caroline G. Tai, Kristin Y. Shiue, Yonatan H. Grad, Deverick J. Anderson, David D. Ho, Leroy Sims, Christopher LeMay, Jimmie Mancell, Lisa L. Maragakis

Summary: In this retrospective cohort study of the 2020 NBA closed campus occupational health program, recovered individuals who continued to test positive for SARS-CoV-2 following discontinuation of isolation were not infectious to others. These findings support time-based US Centers of Disease Control and Prevention recommendations for ending isolation.

JAMA INTERNAL MEDICINE (2021)

Article Public, Environmental & Occupational Health

Barriers to implementing antimicrobial stewardship programs in three low- and middle-income country tertiary care settings: findings from a multi-site qualitative study

Robert Rolfe, Charles Kwobah, Florida Muro, Anushka Ruwanpathirana, Furaha Lyamuya, Champica Bodinayake, Ajith Nagahawatte, Bhagya Piyasiri, Tianchen Sheng, John Bollinger, Chi Zhang, Truls Ostbye, Shamim Ali, Richard Drew, Peter Kussin, Deverick J. Anderson, Christopher W. Woods, Melissa H. Watt, Blandina T. Mmbaga, L. Gayani Tillekeratne

Summary: This study identified important barriers to implementing ASPs in three tertiary care centers in LMICs, including improving drug availability, enhancing availability of and trust in microbiologic data, developing local guidelines, and providing education to physicians regarding antimicrobial prescribing.

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2021)

Article Immunology

Impact of Antibiotic Stewardship Rounds in the Intensive Care Setting: A Prospective Cluster-Randomized Crossover Study

Jessica L. Seidelman, Nicholas A. Turner, Rebekah H. Wrenn, Christina Sarubbi, Deverick J. Anderson, Daniel J. Sexton, Rebekah W. Moehring

Summary: Weekly multidisciplinary antibiotic stewardship rounds in the intensive care units were associated with a small reduction in antibiotic use, with differential effects observed among specialty units. Customizing antibiotic stewardship rounds to match unit-specific population, workflow, and culture is important for maximizing effectiveness.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile

Nicholas A. Turner, Bobby G. Warren, Maria F. Gergen-Teague, Rachel M. Addison, Bechtler Addison, William A. Rutala, David J. Weber, Daniel J. Sexton, Deverick J. Anderson

Summary: Fidaxomicin and vancomycin are more effective in reducing C. difficile shedding and environmental contamination compared to metronidazole. Treatment choice may play a role in reducing healthcare-associated C. difficile transmission.

CLINICAL INFECTIOUS DISEASES (2022)

Article Public, Environmental & Occupational Health

Comparison of metrics used to track central-line-associated bloodstream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs) across a regional network

Sonali D. Advani, Becky A. Smith, Jessica Seidelman, Nicholas Turner, Deverick J. Anderson, Sarah S. Lewis

Summary: The paradoxical relationship between standardized infection ratio and standardized utilization ratio for CAUTIs compared to CLABSIs, along with challenges in CAUTI definition, incentivizes hospitals to prioritize prevention efforts on urine culture stewardship.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Article Public, Environmental & Occupational Health

The impact of patient-reported penicillin or cephalosporin allergy on surgical site infections

Jessica L. Seidelman, Rebekah W. Moehring, David J. Weber, Deverick J. Anderson, Sarah S. Lewis

Summary: Patients who reported a penicillin or cephalosporin allergy had a higher risk of developing a surgical site infection (SSI) compared to non-allergic patients. However, the choice of surgical prophylaxis did not significantly affect this association. The reported allergy may serve as a surrogate marker for a more complex patient population.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Article Public, Environmental & Occupational Health

Challenges in hospital-acquired coronavirus disease 2019 (COVID-19) surveillance and attribution of infection source

Sarah S. Lewis, Ibukunoluwa C. Kalu, Jessica Seidelman, Deverick J. Anderson, Rebekah W. Moehring, Becky A. Smith

Summary: The study found that without real-time adjudication, nearly 50% of HA-COVID-19 cases identified using electronic definitions were misclassified. Both electronic and traditional contact tracing methods likely underestimated the incidence of HA-COVID-19.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Article Public, Environmental & Occupational Health

Risk of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) acquisition during ambulance transport: A retrospective propensity-score-matched cohort analysis

Diego Schaps, Andrew W. Godfrey, Deverick J. Anderson

Summary: This study found that patients who were transported to the emergency department by ambulance had a higher risk of developing MRSA or VRE within 30 days compared to those who arrived by private vehicle.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Article Public, Environmental & Occupational Health

Harvesting the low-hanging fruit? Comparative assessment of intravenous to oral route antimicrobial conversion policy implementation

Rebekah W. Moehring, Angelina Davis, Elizabeth Dodds Ashley, April P. Dyer, Richard H. Drew, Yuliya Loknyghina, Melissa D. Johnson, Travis M. Jones, S. Shaefer Spires, Daniel J. Sexton, Deverick J. Anderson

Summary: Policies promoting converting antibiotics from intravenous to oral administration are crucial for hospital antimicrobial stewardship programs, and developing metrics and comparison methods can help improve implementation.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Review Allergy

Therapeutic monoclonal antibodies with a focus on hereditary angioedema

Bruce L. Zuraw, Marcus Maurer, Daniel J. Sexton, Marco Cicardi

Summary: Monoclonal antibodies (mAbs) have shown efficacy and safety in various therapeutic areas. This article discusses the advantages and limitations of mAbs compared to small molecules and introduces a novel mAb for the treatment of hereditary angioedema (HAE), a rare and life-threatening condition characterized by recurrent swelling attacks. Lanadelumab, a fully human mAb targeting plasma kallikrein, has demonstrated promising results in clinical trials, including a pivotal Phase 3 study. It has the potential to provide an effective and less burdensome treatment option for HAE patients.

ALLERGOLOGY INTERNATIONAL (2023)

No Data Available